Combining today’s most innovative approaches to medicine with a long tradition of excellence in physician training and patient care.
There are few disciplines that are being transformed more rapidly than the field of healthcare, and the practice of medicine.
In the Division of Rheumatology, Allergy & Immunology we are working to gain new insights and knowledge about the causes as – well as ways to prevent and treat – a broad spectrum of rheumatologic, allergic and immunologic diseases.
We are passionate about ongoing research that continually yields important new scientific data. We are committed to finding ways to provide the best possible care through the use of therapeutic options that are currently available as well as the new ones we help to develop. Just as importantly, we learn each day from our most important teachers of all; our patients.
Our goals are to access today’s most advanced medical approaches and provide the best physician training, with a focus on providing individualized and compassionate patient care.
This comprehensive, yet focused approach, partnered with our belief in the importance of patient-centered care is at the core of our mission.
At the end of the day, this approach creates a very positive impact – both in the way that our physicians practice medicine, as well as in the lives of our patients and their families.
UNC Thurston Arthritis Research Center
Learn how the UNC Thurston Arthritis Research Center is providing healing and hope for people with Arthritis, Allergies and Autoimmune Diseases.
Rheumatology, Allergy & Immunology News
-
Fellows Match to the Department of Medicine
While the pandemic made this year particularly challenging for fellowship recruitment efforts and interviews, a series of videos showing each program’s strengths was a creative solution, introducing viewers to faculty and current fellows, with a brief glimpse into what it might be like to join the program. And although it was impossible to replicate the … Continued
-
Kim Says Allergic Reactions to COVID-19 Vaccine Likely To Be Extremely Rare
As the US Food and Drug Administration considers whether to authorize emergency use of Pfizer and BioNTech’s COVID-19 vaccine, medical experts are paying close attention to reports of allergic reactions to the vaccine. Edwin Kim, MD, associate professor of medicine and pediatrics in the division of rheumatology, allergy and immunology, says it’s not immediately clear to … Continued
-
Sheikh Leads Largest Ever Double-Blinded, Placebo-Controlled SLE Study
Saira Sheikh, MD, led the “BASE” study, now published in The Lancet Rheumatology, which found mortality, AESIs among SLE (Systemic Lupus Erythematosus) patients taking Benlysta similar to placebo. Learn more from the UNC Health and UNC School of Medicine Newsroom.